Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Inari Medical, Inc. is a commercial-stage medical device company intensely focused on developing and commercializing innovative catheter-based technologies for the treatment of venous thromboembolism (VTE). Their flagship products, the ClotTriever system for deep vein thrombosis (DVT) and the FlowTriever system for pulmonary embolism (PE), are designed to extract large clots from large vessels without the need for thrombolytic drugs. Inari Medical is committed to transforming the treatment paradigm for VTE, aiming to provide safer, more effective, and less invasive options that significantly improve patient outcomes.
The Irvine headquarters serves as the global command center for Inari Medical, housing its executive leadership, research and development labs, primary manufacturing oversight, quality assurance, and core administrative functions.
The headquarters comprises modern office spaces and state-of-the-art R&D and manufacturing facilities, designed to foster innovation and collaboration in the development of life-saving medical devices.
Inari Medical fosters a dynamic, patient-focused work culture centered on innovation, scientific rigor, and a commitment to addressing unmet needs in VTE treatment. Employees often describe a fast-paced environment driven by a shared mission to impact patient lives.
As the birthplace of Inari's groundbreaking VTE technologies, the Irvine headquarters is pivotal to the company's strategy, product development pipeline, and global commercial operations. Its location in a leading med-tech ecosystem facilitates access to talent and industry partnerships.
Inari Medical has established a significant global presence, primarily through direct sales and clinical support teams in the United States and key European markets. Functions supported globally include commercial operations (sales, marketing, distribution), physician training and education on their VTE devices, post-market surveillance, regulatory affairs management for international approvals, and conducting clinical trials to further validate and expand indications for their technologies worldwide.
6001 Oak Canyon, Suite 100
Irvine
California
USA
Address: Leopoldstrasse 244, 80807 Munich, Germany
To lead commercial expansion, manage regulatory compliance, and provide clinical and technical support for Inari Medical's products in the European region, adapting strategies to local market needs.
Address: The Gridiron Building, 1 Pancras Square, London, N1C 4AG, United Kingdom
To drive adoption of Inari's VTE solutions within the UK, engage with key opinion leaders, and navigate the specific regulatory and reimbursement landscape of the United Kingdom.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Inari Medical' leadership includes:
Inari Medical has been backed by several prominent investors over the years, including:
Over the past year, Inari Medical has seen key leadership changes, including the appointment of Drew Hykes as CEO, succeeding Bill Hoffman who retired from the role. The company also welcomed Tara Dunn as Chief Business Development and Strategy Officer. Additionally, CFO Mitch Hill announced his planned retirement in 2024.
Discover the tools Inari Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Inari Medical typically uses a standardized email format for its employees, which is common among corporations. The most prevalent format combines the first initial of an employee's name with their full last name.
[first_initial][last]@inarimedical.com
Format
jdoe@inarimedical.com
Example
90%
Success rate
GlobeNewswire • May 7, 2024
Inari Medical reported its financial results for the first quarter ended March 31, 2024. The company highlighted continued revenue growth, driven by the increasing adoption of its ClotTriever and FlowTriever systems, and provided updates on its commercial expansion and product development initiatives....more
GlobeNewswire • March 5, 2024
Inari Medical, Inc. announced that Mitch Hill, Chief Financial Officer, has decided to retire in 2024. Mr. Hill will continue in his role through the transition period, including the search for and appointment of his successor, to ensure a seamless transition....more
GlobeNewswire • February 27, 2024
Inari Medical reported financial results for the fourth quarter and full year ended December 31, 2023, showcasing substantial revenue growth and increased market penetration of its VTE treatment solutions. The company emphasized its ongoing commitment to innovation and expanding patient access....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Inari Medical, are just a search away.